Aster DM Quality Care Limited
Aster DM Quality Care Limited (ASTERDM) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
asterdmhealthcare.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Stock price
₹759.90
Market cap
39,373 Cr
Stock P/E
131.2
P/B
8.10
Dividend yield
0.1%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,317 Cr | 3,711 Cr | 974 Cr | 1,002 Cr | 1,086 Cr | 1,050 Cr | 1,000 Cr | 1,078 Cr | 1,197 Cr | 1,186 Cr | 1,182 Cr | 1,311 Cr |
| Operating expenses (approx.) | 2,939 Cr | 3,146 Cr | 814 Cr | 838 Cr | 867 Cr | 861 Cr | 808 Cr | 871 Cr | 947 Cr | 975 Cr | 950 Cr | 1,046 Cr |
| EBITDA | 377 Cr | 564 Cr | 159 Cr | 164 Cr | 220 Cr | 189 Cr | 192 Cr | 207 Cr | 250 Cr | 211 Cr | 233 Cr | 264 Cr |
| OPM % | 11.4% | 15.2% | 16.4% | 16.3% | 20.2% | 18.0% | 19.2% | 19.2% | 20.9% | 17.8% | 19.7% | 20.2% |
| Other income | 9 Cr | 8 Cr | 4 Cr | 49 Cr | 35 Cr | 33 Cr | 31 Cr | 33 Cr | 28 Cr | 28 Cr | 36 Cr | 37 Cr |
| Interest | 102 Cr | 99 Cr | 30 Cr | 29 Cr | 31 Cr | 31 Cr | 32 Cr | 31 Cr | 31 Cr | 31 Cr | 30 Cr | 31 Cr |
| Depreciation | 227 Cr | 232 Cr | 58 Cr | 60 Cr | 62 Cr | 62 Cr | 64 Cr | 63 Cr | 66 Cr | 68 Cr | 67 Cr | 69 Cr |
| Profit before tax | -5 Cr | 233 Cr | 32 Cr | 5,191 Cr | 159 Cr | 102 Cr | 91 Cr | 136 Cr | 167 Cr | 103 Cr | 163 Cr | 78 Cr |
| Tax % | -197.1% | 10.4% | 96.7% | 0.8% | 33.3% | 36.8% | 5.5% | 31.4% | 27.3% | 43.1% | 6.0% | 62.5% |
| Net profit | -15 Cr | 209 Cr | -2 Cr | 5,152 Cr | 106 Cr | 64 Cr | 86 Cr | 94 Cr | 121 Cr | 59 Cr | 154 Cr | 29 Cr |
| EPS (₹) | ₹-0.62 | ₹3.60 | ₹-0.48 | ₹103.34 | ₹1.94 | ₹1.14 | ₹1.59 | ₹1.67 | ₹2.13 | ₹1.02 | ₹2.72 | ₹0.31 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,963 Cr | 8,739 Cr | 8,608 Cr | 10,253 Cr | 11,933 Cr | 3,699 Cr | 4,138 Cr | 4,643 Cr | Sign in for TTM |
| Operating expenses (approx.) | 7,100 Cr | 7,481 Cr | 7,546 Cr | 8,770 Cr | 10,368 Cr | 3,121 Cr | 3,374 Cr | 3,742 Cr | Sign in for TTM |
| EBITDA | 863 Cr | 1,258 Cr | 1,063 Cr | 1,483 Cr | 1,565 Cr | 578 Cr | 765 Cr | 901 Cr | Sign in for TTM |
| OPM % | 10.8% | 14.4% | 12.3% | 14.5% | 13.1% | 15.6% | 18.5% | 19.4% | Sign in for TTM |
| Other income | 35 Cr | 38 Cr | 50 Cr | 51 Cr | 78 Cr | 25 Cr | 148 Cr | 126 Cr | Sign in for TTM |
| Interest | 179 Cr | 360 Cr | 294 Cr | 257 Cr | 329 Cr | 110 Cr | 124 Cr | 123 Cr | Sign in for TTM |
| Depreciation | 306 Cr | 586 Cr | 618 Cr | 641 Cr | 780 Cr | 220 Cr | 249 Cr | 264 Cr | Sign in for TTM |
| Profit before tax | 410 Cr | 330 Cr | 205 Cr | 637 Cr | 535 Cr | 342 Cr | 5,542 Cr | 570 Cr | Sign in for TTM |
| Tax % | 10.5% | 4.7% | 13.3% | 5.6% | 11.1% | 16.5% | 2.4% | 25.0% | Sign in for TTM |
| Net profit | 367 Cr | 315 Cr | 178 Cr | 601 Cr | 475 Cr | 212 Cr | 5,408 Cr | 427 Cr | Sign in for TTM |
| EPS (₹) | ₹6.63 | ₹5.51 | ₹2.97 | ₹10.58 | ₹8.55 | ₹2.60 | ₹107.98 | ₹7.53 | Sign in for TTM |
| Dividend payout % | — | — | — | 3.4% | 5.7% | 8.5% | 114.2% | 12.9% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 505 Cr | 500 Cr | 497 Cr | 497 Cr | 500 Cr | 500 Cr | 500 Cr | 518 Cr |
| Reserves | 2,709 Cr | 2,773 Cr | 2,875 Cr | 3,456 Cr | 3,949 Cr | 4,060 Cr | 2,929 Cr | 4,058 Cr |
| Borrowings | — | — | — | — | 2,287 Cr | 669 Cr | 642 Cr | 701 Cr |
| Other liabilities | 5,723 Cr | 9,166 Cr | 8,271 Cr | 8,593 Cr | 7,733 Cr | 12,292 Cr | 2,313 Cr | 2,577 Cr |
| Total liabilities | 8,936 Cr | 12,438 Cr | 11,643 Cr | 12,546 Cr | 14,881 Cr | 17,991 Cr | 6,606 Cr | 8,112 Cr |
| Fixed assets (net) | — | — | — | — | 4,629 Cr | 2,880 Cr | 3,628 Cr | 2,619 Cr |
| CWIP | — | — | — | — | 255 Cr | 170 Cr | 291 Cr | 413 Cr |
| Investments | — | — | — | — | 80 Cr | 17 Cr | 245 Cr | 1,167 Cr |
| Inventories | — | — | — | — | 1,306 Cr | 111 Cr | 92 Cr | 91 Cr |
| Trade receivables | — | — | — | — | 2,336 Cr | 233 Cr | 258 Cr | 307 Cr |
| Cash & bank | — | — | — | — | 379 Cr | 82 Cr | 165 Cr | 228 Cr |
| Other assets | 8,936 Cr | 12,438 Cr | 11,643 Cr | 12,546 Cr | 5,898 Cr | 14,498 Cr | 1,928 Cr | 3,288 Cr |
| Total assets | 8,936 Cr | 12,438 Cr | 11,643 Cr | 12,546 Cr | 14,881 Cr | 17,991 Cr | 6,606 Cr | 8,112 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 1,313 Cr | 1,834 Cr | 158 Cr | 425 Cr | 656 Cr |
| Cash from investing | — | — | — | -570 Cr | -972 Cr | -885 Cr | 6,015 Cr | -288 Cr |
| Cash from financing | — | — | — | -685 Cr | -817 Cr | 1,053 Cr | -6,358 Cr | -304 Cr |
| Net cash flow | — | — | — | 65 Cr | 66 Cr | 332 Cr | 82 Cr | 63 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 765 Cr | 986 Cr | -648 Cr | 68 Cr | 178 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 18.3% | 21.1% | 14.8% | 22.6% | 12.1% | 7.9% | 132.0% | 12.5% |
| ROE % | 10.4% | 8.5% | 4.4% | 13.3% | 8.7% | 2.6% | 147.3% | 8.0% |
| Debtor days | — | — | — | — | 71 | 23 | 23 | 24 |
| Inventory days | — | — | — | — | 40 | 11 | 8 | 7 |
| Days payable | — | — | — | — | 91 | 45 | 37 | 38 |
| Cash conversion cycle | — | — | — | — | 20 | -11 | -7 | -7 |
| Debt / equity | — | — | — | — | 0.51 | 0.15 | 0.19 | 0.15 |
| Current ratio | — | — | — | — | 1.06 | 0.65 | 2.16 | 1.99 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 1.22 | 1.02 | 0.62 | 0.53 |
Compare with peers
Loading peers…